Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
- Authors
- Jacob, Abraham; Ghia, Paolo; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kraychok, Iryna; Illes, Arpad; De La Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Avery, Eric Joseph; Lee, Jae Hoon; Wang, Denise; Patel, Priti; Quah, Cheng Seok; Jurczak, Wojciech
- Issue Date
- Apr-2021
- Publisher
- WILEY
- Citation
- BRITISH JOURNAL OF HAEMATOLOGY, v.193, pp.141 - 142
- Journal Title
- BRITISH JOURNAL OF HAEMATOLOGY
- Volume
- 193
- Start Page
- 141
- End Page
- 142
- ISSN
- 0007-1048
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Jae Hoon
- College of Medicine (Department of Medicine)